Bactobio Raises £6 Million To Discover Novel Antibiotics
06 December 2022
Bactobio Ltd, a Granatus Ventures portfolio company, has closed an oversubscribed £6 million bridge financing round.
The announced funds will be used to advance Bactobio’s pioneering discovery pipeline of the next generation of antimicrobial solutions.
Bactobio is a biotechnology company using breakthrough technologies in synthetic biology, next-generation sequencing and machine learning to cultivate the 99% of microbes in nature which have previously been unculturable.
Granatus is among the first investors in the company.